Phase II study of TS-1+CPT-11+BV followed by TS-1+L-OHP+BV in unresectable advanced colorectal cancer with RAS mutation
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: SOX+BEV and IRIS+BEV sequential therapy Primary outcome(s): Second progression free survival Study Design: Single arm Non-randomized
创建时间：
2014-08-15
